- This event has passed.
HALO 2023 Q1
February 21, 2023
Halozyme Therapeutics (HALO) reports qtrly profits (EPS) and revenues:
- Reported: $0.48 vs. $0.42 = +14%
- Estimates: $0.45 vs. $0.42 = +7%
- Beat the street by $0.03
- Revenue: +78%
- Revenue Est: +86%
Halozyme Therapeutics (HALO) reports qtrly profits (EPS) and revenues:
